Status:
COMPLETED
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
Lead Sponsor:
Hui Zhuang
Collaborating Sponsors:
Guangxi Center for Disease Control and Prevention
Conditions:
Hepatitis B
Immune Response
Eligibility:
All Genders
16-30 years
Phase:
PHASE4
Brief Summary
At present, children less than 15 y of age have been regarded as a key group for hepatitis B immunization in China. However, there is not yet special immunization strategy for population above 15 y of...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male and female freshmen in one college in Liuzhou city of Guangxi Zhuang Autonomous Region
- Exclusion Criteria for vaccination study:
- acute illness
- immunocompromised conditions
- renal insufficiency
- pregnancy
- allergic history to HB vaccine or yeast
- positive for any of HBsAg, anti-HBs or anti-HBc
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2040 Patients enrolled
Trial Details
Trial ID
NCT01861613
Start Date
September 1 2009
Last Update
May 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangxi Centers for Disease Control and Prevention
Nanning, Guangxi, China